Syngene International Limited (SYNGENE.NS)

INR 721.4

(2.79%)

EBITDA Summary of Syngene International Limited

Syngene International Limited's latest annual EBITDA in 2023 was 10.84 Billion INR , up 6.46% from previous year.
Syngene International Limited's latest quarterly EBITDA in 2024 Q2 was 2.61 Billion INR , up 18.83% from previous quarter.
Syngene International Limited reported an annual EBITDA of 9.87 Billion INR in 2022, up 18.91% from previous year.
Syngene International Limited reported an annual EBITDA of 8.07 Billion INR in 2021, up 13.97% from previous year.
Syngene International Limited reported a quarterly EBITDA of 2.61 Billion INR for 2024 Q2, up 18.83% from previous quarter.
Syngene International Limited reported a quarterly EBITDA of 3.26 Billion INR for 2023 Q4, up 25.35% from previous quarter.

Annual EBITDA Chart of Syngene International Limited (2023 - 2009)

Historical Annual EBITDA of Syngene International Limited (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	10.84 Billion INR	6.46%
2022	9.87 Billion INR	18.91%
2021	8.07 Billion INR	13.97%
2020	7.67 Billion INR	6.46%
2019	7.66 Billion INR	14.96%
2018	6.05 Billion INR	20.95%
2017	5.26 Billion INR	6.12%
2016	4.78 Billion INR	32.34%
2015	3.86 Billion INR	24.76%
2014	2.92 Billion INR	28.6%
2013	2.22 Billion INR	31.99%
2012	1.72 Billion INR	28.23%
2011	1.38 Billion INR	57.37%
2010	1 Billion INR	-4.24%
2009	874 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	1.73 Billion INR	-33.96%
2024 Q2	2.61 Billion INR	18.83%
2023 Q4	3.26 Billion INR	25.35%
2023 Q3	2.6 Billion INR	-5.4%
2023 FY	- INR	6.46%
2023 Q1	2.35 Billion INR	-30.1%
2023 Q2	2.75 Billion INR	17.07%
2022 FY	- INR	18.91%
2022 Q2	2.31 Billion INR	23.15%
2022 Q3	2.48 Billion INR	7.03%
2022 Q1	1.88 Billion INR	-19.63%
2022 Q4	3.36 Billion INR	35.74%
2021 Q3	2.16 Billion INR	13.66%
2021 Q4	2.34 Billion INR	8.32%
2021 FY	- INR	13.97%
2021 Q1	1.77 Billion INR	-34.04%
2021 Q2	1.9 Billion INR	7.33%
2020 Q4	2.68 Billion INR	39.06%
2020 Q1	1.41 Billion INR	-36.19%
2020 FY	- INR	6.46%
2020 Q2	1.69 Billion INR	19.7%
2020 Q3	1.93 Billion INR	14.04%
2019 Q1	1.41 Billion INR	-19.09%
2019 Q2	1.59 Billion INR	12.85%
2019 Q4	2.21 Billion INR	27.9%
2019 Q3	1.73 Billion INR	8.57%
2019 FY	- INR	14.96%
2018 Q3	1.57 Billion INR	8.97%
2018 Q2	1.44 Billion INR	12.94%
2018 Q1	1.28 Billion INR	-11.94%
2018 Q4	1.75 Billion INR	10.83%
2018 FY	- INR	20.95%
2017 Q2	1.29 Billion INR	14.75%
2017 Q4	1.45 Billion INR	5.73%
2017 Q1	1.13 Billion INR	-8.93%
2017 FY	- INR	6.12%
2017 Q3	1.37 Billion INR	6.08%
2016 Q1	1.04 Billion INR	-12.97%
2016 Q4	1.24 Billion INR	-2.43%
2016 Q3	1.27 Billion INR	4.51%
2016 Q2	1.21 Billion INR	16.43%
2016 FY	- INR	32.34%
2015 Q1	805 Million INR	-5.96%
2015 FY	- INR	24.76%
2015 Q4	1.2 Billion INR	27.57%
2015 Q3	943 Million INR	8.6%
2015 Q2	868.3 Million INR	7.86%
2014 FY	- INR	28.6%
2014 Q4	856 Million INR	8.91%
2014 Q1	574.8 Million INR	0.0%
2014 Q2	667.9 Million INR	16.2%
2014 Q3	786 Million INR	17.68%
2013 FY	- INR	31.99%
2012 FY	- INR	28.23%
2011 FY	- INR	57.37%
2010 FY	- INR	-4.24%
2009 FY	- INR	0.0%

Peer EBITDA Comparison of Syngene International Limited

Name	EBITDA	EBITDA Difference
Biocon Limited	41.52 Billion INR	73.879%
Blue Jet Healthcare Limited	2.29 Billion INR	-373.193%
Concord Biotech Limited	4.65 Billion INR	-132.813%
Dishman Carbogen Amcis Limited	3.07 Billion INR	-253.115%
Jubilant Ingrevia Limited	4.56 Billion INR	-137.652%
Lyka Labs Limited	167.58 Million INR	-6372.382%
Panacea Biotec Limited	-47.58 Million INR	22897.394%
Piramal Pharma Limited	13.05 Billion INR	16.916%
SMS Lifesciences India Limited	349.41 Million INR	-3004.376%
Supriya Lifescience Limited	1.83 Billion INR	-490.872%
TAKE Solutions Limited	-1.05 Billion INR	1132.222%
Zota Health Care Limited	82.07 Million INR	-13116.283%